RT @MDBpartners Blood Disease Drug Dacogen Gets Thumbs Down For Cancer Use | Biotech/pharma | http://stks.co/2KoK $ASTX $CYCC $CELG

@adamfeuerstein @aafiac $ASTX they now need Sapacitabine from $CYCC even more

$CYCC accumulation at its best

RT @biotech @StockCowboy $ASTX Dacogen FDA ODAC meeting webcast link 8am ET http://stks.co/2KFH $CYCC Sapacitabine on watch today

@Novice67 no, all in $CYCC at the moment

$CYCC .68 premarket $ASTX

@StockCowboy $ASTX Dacogen FDA ODAC meeting webcast link 8am ET http://stks.co/2K1y $CYCC Sapacitabine on watch today

@StockCowboy Lazard Capital $CYCC Dacogen FDA adv. com. for AML should be positive for Sapacitabine,irrespective of outcome BUY PT2.50 $ASTX

@biotech I am planning on $CYCC tomorrow.. looks nice!

$CYCC starting

$CYCC green

$CYCC Cyclacel Pharmaceuticals management to meet with Lazard Capital in Boston on February 10 per flyonthewall

$cycc added more

$CYCC on watch to the upside after $ASTX to the downside